alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.1
  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
  The undersigned, Zhiwei Huang, the Chief Financial Officer of CHINA EXECUTIVE EDUCATION CORP. (the "Company"), do hereby certify that:
  1. The Company’s Amendment No. 1 to the Transition Report on Form 10-K for the for the transition period from April 30, 2009 to January 1, 2010 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.
  IN WITNESS WHEREOF, each of the undersigned has executed this statement this 14th day of August, 2010.
  
 /s/ Zhiwei HuangZhiwei HuangChief Financial Officer
 
  A signed original of this written statement required by Section 906 has been provided to China Executive Education Corp. and will be retained by China Executive Education Corp. and furnished to the Securities and Exchange Commission or its staff upon request.
  The forgoing certification is being furnished to the Securities and Exchange Commission pursuant to § 18 U.S.C. Section 1350. It is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
# Az Európai Unió C 15I/2021

| | ISSN 1977-0979 |
| --- | --- |
| Az Európai Unió
  Hivatalos Lapja | C 015I |
| | |
| Magyar nyelvű kiadás | Tájékoztatások és közlemények | 64. évfolyam2021. január 14. |

ISSN 1977-0979

Az Európai Unió

Hivatalos Lapja

C 015I

Magyar nyelvű kiadás

Tájékoztatások és közlemények

64. évfolyam2021. január 14.

---

| Tartalom | Oldal |
| --- | --- |
| | Helyesbítések |
| | Helyesbítés a következőhöz: Az Európai Parlament, az Európai Unió Tanácsa és az Európai Bizottság együttes nyilatkozata – Az EU 2021. évi jogalkotási prioritásai ( HL C 451 I., 2020.12.29. ) | 1 |
| | Helyesbítés a következőhöz: Az Európai Parlament, az Európai Unió Tanácsa és az Európai Bizottság együttes következtetései a 2020–2024-es időszak szakpolitikai célkitűzéseiről és prioritásairól ( HL C 451 I., 2020.12.29. ) | 2 |

Tartalom

Oldal

Helyesbítések

Helyesbítés a következőhöz: Az Európai Parlament, az Európai Unió Tanácsa és az Európai Bizottság együttes nyilatkozata – Az EU 2021. évi jogalkotási prioritásai ( HL C 451 I., 2020.12.29. )

( HL C 451 I., 2020.12.29. )

1

Helyesbítés a következőhöz: Az Európai Parlament, az Európai Unió Tanácsa és az Európai Bizottság együttes következtetései a 2020–2024-es időszak szakpolitikai célkitűzéseiről és prioritásairól ( HL C 451 I., 2020.12.29. )

( HL C 451 I., 2020.12.29. )

2

---

| HU | |
| --- | --- |

HU

---

Helyesbítések

| 2021.1.14. | HU | Az Európai Unió Hivatalos Lapja | CI 15/1 |
| --- | --- | --- | --- |

2021.1.14.

HU

Az Európai Unió Hivatalos Lapja

CI 15/1

---

Helyesbítés a következőhöz: Az Európai Parlament, az Európai Unió Tanácsa és az Európai Bizottság együttes nyilatkozata – Az EU 2021. évi jogalkotási prioritásai

(
  Az Európai Unió Hivatalos Lapja C 451. I, 2020. december 29.
  )

(2021/C 15 I/01)

Az 1. oldalon megjelent közlemény (2021/C 451 I/01) semmisnek tekintendő.

---

| 2021.1.14. | HU | Az Európai Unió Hivatalos Lapja | CI 15/2 |
| --- | --- | --- | --- |

2021.1.14.

HU

Az Európai Unió Hivatalos Lapja

CI 15/2

---

Helyesbítés a következőhöz: Az Európai Parlament, az Európai Unió Tanácsa és az Európai Bizottság együttes következtetései a 2020–2024-es időszak szakpolitikai célkitűzéseiről és prioritásairól

(
  Az Európai Unió Hivatalos Lapja C 451. I, 2020. december 29.
  )

(2021/C 15 I/02)

A 4. oldalon megjelent közlemény (2021/C 451 I/02) semmisnek tekintendő.

---
EXHIBIT 32. 2





CERTIFICATION OF CHIEF FINANCIAL OFFICER





BIOCANCELL THERAPEUTICS INC.





FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2010





PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED





PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002








I am the Chief Financial Officer of BioCancell Therapeutics Inc., a Delaware corporation (the “Company”). I am delivering this certificate in connection with the Form 10-K of the Company for the year ended December 31, 2010 and filed with the Securities and Exchange Commission (“Form 10-K”).





Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I hereby certify that, to the best of my knowledge, the Form 10-K fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.














Date: March 11, 2011/s/ IRA WEINSTEINIra WeinsteinChief Financial Officer(Principal Financial Officer)
##### 



Exhibit 31.2
 CERTIFICATION OF TREASURER PURSUANT TO SECURITIES
ACT RULES 13a-14 AND 15d-14 AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
  1.
    
    I have reviewed this quarterly report (report) on Form 10-Q of Del Taco Restaurant
Properties II;
 2.
    
    Based on my knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the
period covered by this report;
 3.
    
    Based on my knowledge, the financial statements, and other financial information included
in this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this
report;
 4.
    
    The registrants other certifying officers and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) for the registrant and have:
 a)
    
    Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries, is
made known to us by others within those entities, particularly during the period in
which this report is being prepared;b)
    
    Evaluated the effectiveness of the registrants disclosure controls and
procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures as of the end of the period covered by this report
based on such evaluation; andc)
    
    Disclosed in this report any change in the registrants internal control over
financial reporting that occurred during the registrants most recent fiscal quarter
that has materially affected, or is reasonably likely to materially affect, the
registrants internal control over financial reporting; and
 5.
    
    The registrants other certifying officer and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the
audit committee of the registrants board of directors (or persons performing the equivalent
function):
 a)
    
    All significant deficiencies and material weaknesses in the design or operation
of internal control over financial reporting which are reasonably likely to adversely
affect the registrants ability to record, process, summarize and report financial
information; andb)
    
    Any fraud, whether or not material, that involves management or other employees
who have a significant role in the registrants internal control over financial
reporting.
 Date: May 12, 2006
    /s/ Steven L. BrakeSteven L. BrakeTreasurer
**Exhibit32.1**

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Inconnection with the annual report of U.S. Shipping Partners L.P. (the“Partnership”) on Form 10-K for the fiscal year ended December 31, 2005 asfiled with the Securities and Exchange Commission (the “Report”), I, Paul B.Gridley, Chairman and Chief Executive Officer of US Shipping General PartnerLLC, the general partner of the Partnership, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(i)The Report fully complies with the requirements of section 13(a) or 15(d) ofthe Securities Exchange Act of 1934 and (ii) the information contained in theReport fairly presents, in all material respects, the financial condition andresults of operations of the Company.

 

 
|   | /s/ Paul B. Gridley                   |   |
|--------|---------------------------------------|--------|
|   | Paul B. Gridley                       |
|   | Chairman and Chief  Executive Officer |
|   | March 15, 2006                        |

 

Asigned original of this written statement required by Section 906 has beenprovided to U.S. Shipping Partners L.P. and will be retained by U.S. ShippingPartners L.P. and furnished to the Securities and Exchange Commission or itsstaff upon request.

 

----
STATE EX REL. Edward MCGARY v. STATE of Louisiana

No. 2016-KH-2132

Supreme Court of Louisiana.

March 2, 2018

**ON SUPERVISORY WRITS TO THE TWENTY-FIRST JUDICIAL DISTRICT COURT, PARISH OF TANGIPAHOA**

PER CURIAM:

Denied. Relator does not identify an illegal term in his sentence, and therefore, *499his filing is properly construed as an application for post-conviction relief. *See* *State v. Parker* , 98-0256 (La. 5/8/98), 711 So.2d 694. As such, it is subject to the time limitation set forth in La.C.Cr.P. art. 930.8. Relator's application was not timely filed in the district court, and he fails to carry his burden to show that an exception applies. La.C.Cr.P. art. 930.8 ; *State ex rel. Glover v. State* , 93-2330 (La. 9/5/95), 660 So.2d 1189. In addition, relator's sentencing claim is not cognizable on collateral review. La.C.Cr.P. art. 930.3 ; *State ex rel. Melinie v. State,* 93-1380 (La. 1/12/96), 665 So.2d 1172, *see also* *State v. Cotton,* 09-2397 (La. 10/15/10), 45 So.3d 1030. Relator's claim is also repetitive. La.C.Cr.P. art. 930.4.

Relator has now fully litigated several applications for post-conviction relief in state court. Similar to federal habeas relief, *see* 28 U.S.C. § 2244, Louisiana post-conviction procedure envisions the filing of a successive application only under the narrow circumstances provided in La.C.Cr.P. art. 930.4 and within the limitations period as set out in La.C.Cr.P. art. 930.8. Notably, the Legislature in 2013 La. Acts 251 amended that article to make the procedural bars against successive filings mandatory. Relator's claims have now been fully litigated in accord with La.C.Cr.P. art. 930.6, and this denial is final. Hereafter, unless he can show that one of the narrow exceptions authorizing the filing of a successive application applies, relator has exhausted his right to state collateral review. The district court is ordered to record a minute entry consistent with this per curiam.
Jonah PARKER, Appellant, v. STATE of Florida, Appellee.

CASE NO. 1D17-1922

District Court of Appeal of Florida, First District.

Opinion filed November 13, 2017

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
Marcus B. HARRIS, Appellant/Petitioner(s), v. William F. CRENSHAW, CEO of Publix Supermarkets, Inc., Appellee/Respondent(s).

CASE NO.: 2D17-3578

District Court of Appeal of Florida, Second District.

October 11, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Mandamus is denied.
Timothy BOBERG, Appellant, v. Thomas W. CONLEY, III, Appellee.

No. 4D17-2469

District Court of Appeal of Florida, Fourth District.

[February 1, 2018]

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Labor

###### Employment and Training Administration 

          - [TA-W-65,165] 

Pursuant to Section 221 of the Trade Act of 1974, as amended, an investigation was initiated on February 9, 2009 in response to a petition filed by the International Union, United Automobile, United Aerospace and Agricultural Implement Workers of America, Local 889 on behalf of workers of Chrysler National Customer Service Center, Rochester Hills, Michigan. 

The petitioner has requested that the petition be withdrawn. Consequently, the investigation has been terminated. 

Signed at Washington, DC, this 19th day of March 2009. 

Linda G. Poole, 

Certifying Officer, Division of Trade Adjustment Assistance. 

 [FR Doc. E9-7748 Filed 4-6-09; 8:45 am] 

BILLING CODE 4510-FN-P
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THE FINANCIAL DATA SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
FROM TEXOIL QUARTERLY REPORT 03/31/00 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER>                    1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                           3,585
<SECURITIES>                                         0
<RECEIVABLES>                                    7,267
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                11,083
<PP&E>                                          69,688
<DEPRECIATION>                                (11,886)
<TOTAL-ASSETS>                                  69,117
<CURRENT-LIABILITIES>                            7,977
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                         28
<COMMON>                                            67
<OTHER-SE>                                      37,741
<TOTAL-LIABILITY-AND-EQUITY>                    69,117
<SALES>                                         10,614
<TOTAL-REVENUES>                                11,017
<CGS>                                            3,809
<TOTAL-COSTS>                                      547
<OTHER-EXPENSES>                                 1,795
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 382
<INCOME-PRETAX>                                  4,484
<INCOME-TAX>                                     1,502
<INCOME-CONTINUING>                              2,982
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,982
<EPS-BASIC>                                        .36
<EPS-DILUTED>                                      .24


</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

                    Notice is hereby given of a change in the meeting of the Population Sciences Subcommittee, February 9, 2017, 08:00 a.m. to February 9, 2017, 05:00 p.m., Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD, 20814 which was published in the                     **Federal Register**                     on December 18, 2017, Vol. 82 242479 Pg. 60026.                

The meeting date has changed from February 9, 2017, 8:00 a.m. to 5:00 p.m. to February 9, 2018, 8:00 a.m. to 5:00 p.m. The meeting is closed to the public.

Dated: January 10, 2018.

Michelle Trout,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2018-00868 Filed 1-18-18; 8:45 am]

 BILLING CODE 4140-01-P
Exhibit 32.2



CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Silver Falcon Mining, Inc., a Delaware corporation (the "Company"), does hereby certify, to the best of his knowledge, that:



1.     The Annual Report on Form 10-K for the period ending December 31, 2010 (the "Report") of the Company complies in all material respects with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and



2.     The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



/s/ Thomas C. Ridenour

Thomas C. Ridenour,

Chief financial Officer

(principal financial and accounting officer)



Date:  March 24, 2011
Mr
. Ronald W. Gore Chief, Air Di vision UNITED STATES ENVIRONMENTAL PROTECTION AGENCY REG I ON 4 ATLANTA FEDERAL CENTER 6 1 FORSYTH STREET AT LANTA , GEORG I A 30303 -8960



# .A PR l 

# 8 

# £(Hti

Alabama Department of Environmental Management P.O. Box 301463 Montgomery, Alabama 36130-1463 Dear Mr. Gore: Enclosed is the fmal end-of- year report for your agency's FY 2015 Air Pollution Control grant authorized by 

### § 105 of the Clean Air Act. This report outlines your agency's various grant comm itments and their status. S ince there were no issues and no ad justments necessary, your report is now finalized. This letter documents the conclusion of the joint evaluation process required by 40 Code of Federal Regulations 35.115 and identified as a commitment in your FY 2015 Air Planning Agreement under Cross Cutting Issues. We app rec iate the progress you made in FY 2015 and look forward to continuing ourjoint efforts to protect and improve air quality. If you have any questions regarding your grant , please contact Stuart Pen·y at (404) 562-8980 or Gwendolyn Grafat (404) 562-9289.

Enclosure Caro l L. Kemker Acting Dir ector Air , Pesticides and Toxics Management Division

I nterne t Address ( URL) • http :// www .e p a. g ov Recyc l ed/Recyc l ab l e • P ri n ted w i th Vege table O i l Based I nks on Recyc l ed Paper (M i n i mum 30 % Pos tconsume r )
Exhibit 99.01

                Written Statement of the Chief Financial Officer and Chief
                    Executive Officer Pursuant to 18 U.S.C.  1350

Solely for the purposes of complying with 18 U.S.C. 1350, I,  the undersigned
Chief  Financial Officer of  Sealife Corporation.  (the "Company"),  hereby
certify, based on  my  knowledge,  that  the Quarterly  Report  on Form 10-Q of
the Company  for  the  quarter ended  August 31,  2003  (the "Report") fully
complies  with  the requirements of Section 13(a) of the Securities Exchange
Act  of 1934   and  that  information  contained  in  the  Report  fairly
presents,  in all material respects, the financial condition  and results of
operations of the Company.


By:   /s/ Robert McCaslin
          ---------------
          Robert McCaslin
          Chief Financial Officer

Date:    November 6, 2003
[Federal Register Volume 74, Number 10 (Thursday, January 15, 2009)]
[Notices]
[Page 2618]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-773]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated October 9, 2008, and published in the Federal 
Register on October 17, 2008 (73 FR 61908), Noramco Inc., 500 Swedes 
Landing Road, Wilmington, Delaware 19801-4417, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as an importer of Opium, Raw (9600) and Concentrate of Poppy Straw 
(9670), basic classes of controlled substances listed in schedule II.
    The company plans to import the listed controlled substances to 
manufacture other controlled substances.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and Sec.  952(a) and determined that 
the registration of Noramco, Inc., to import the basic class of 
controlled substance is consistent with the public interest, and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971, at this time. DEA has investigated 
Noramco, Inc., to ensure that the company's registration is consistent 
with the public interest. The investigation has included inspection and 
testing of the company's physical security systems, verification of the 
company's compliance with state and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 
952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above 
named company is granted registration as an importer of the basic class 
of controlled substance listed.

    Dated: January 9, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-773 Filed 1-14-09; 8:45 am]
BILLING CODE 4410-09-P
CROSSTEX ENERGY SERVICES, LP, Crosstex Lig, LLC, and Crosstex Processing Services, LC v. TEXAS BRINE COMPANY, LLC, et al.

No. 2018-C-0144

Supreme Court of Louisiana.

March 23, 2018

**ON WRIT OF CERTIORARI TO THE COURT OF APPEAL, FIRST CIRCUIT, PARISH OF ASSUMPTION**

Writ denied.

Crichton, J., would grant and assigns reasons.

Crichton, J., would grant and assigns reasons.

*963I would grant this writ application to review whether the court of appeal correctly affirmed the trial court's decision to grant summary judgment in favor of the insurer in this matter. In particular, I would investigate whether the allegations in the petition, when liberally interpreted, *see**Yount v. Maisano* , 627 So.2d 148 (La. 1993), raise even the possibility of liability during the coverage period.